Shareholder alert: pomerantz law firm investigates claims on behalf of investors of acadia pharmaceuticals inc. - acad

New york, march 11, 2024 /prnewswire/ -- pomerantz llp is investigating claims on behalf of investors of acadia pharmaceuticals inc. ("acadia" or the "company") (nasdaq: acad). such investors are advised to contact danielle peyton at newaction@pomlaw.com or 646-581-9980, ext.
ACAD Ratings Summary
ACAD Quant Ranking